Pain assessment in Alzheimer’s disease and related dementias (ADRD) is challenging due to cognitive decline and communication barriers, limiting the reliability of self-report and observational tools. Functional near-infrared spectroscopy (fNIRS) offers a noninvasive measure of cerebral hemodynamic responses and may serve as an objective biomarker for pain. This pilot study evaluated the feasibility of fNIRS for pain assessment in ADRD, using transcranial direct current stimulation (tDCS) solely as a controlled cortical modulation paradigm to test fNIRS sensitivity, rather than as a therapeutic intervention.
Methods
Forty older adults with mild to moderate ADRD were randomized to active (n = 20) or sham (n = 20) tDCS for 5 consecutive days to generate controlled cortical modulation. Pain was assessed using the Numerical Rating Scale (NRS), Mobilization-Observation-Behavior-Intensity-Dementia-2 (MOBID-2), and fNIRS responses to standardized pain stimuli. Hemodynamic changes in prefrontal and somatosensory cortices were analyzed to determine whether fNIRS detected pain-related brain activity.
Results
NRS and MOBID-2 scores were significantly correlated at baseline (r = .605, p < .001) and post-intervention (r = .567, p < .001). In the active tDCS condition, pain stimulation elicited significant cortical hemodynamic changes that correlated with pain scores (p < .05), supporting fNIRS’s sensitivity for detecting pain-related neural responses. In the sham group, only a few significant correlations were observed post-intervention (e.g., frontal cortex r = .44, p = .049; prefrontal cortex r = .52, p = .017), which were less consistent compared to the active condition.
Conclusion
fNIRS demonstrated feasibility as an objective pain assessment tool in ADRD. tDCS served only as a probe to induce cortical modulation for evaluating fNIRS performance. In this study, tDCS functioned as a probe to induce cortical modulation for evaluating fNIRS sensitivity, not as a therapeutic intervention. Larger trials are needed to confirm fNIRS validity for clinical application.
ZelayaCEDahlhamerJMLucasJW, et al.Chronic Pain and High-impact Chronic Pain Among U.S. Adults. NCHS Data Brief, 2019, vol 2020, pp. 1–8.
3.
DagninoAPACamposMM. Chronic pain in the elderly: mechanisms and perspectives. Front Hum Neurosci2022; 16: 736688–20220303.
4.
KaufmannLMoellerKMarksteinerJ. Pain and associated neuropsychiatric symptoms in patients suffering from dementia: challenges at different levels and proposal of a conceptual framework. J Alzheimers Dis2021; 83: 1003–1009.
5.
AchterbergWLautenbacherSHuseboB, et al.Pain in dementia. Pain Rep2020; 5: e803–e20191225.
6.
HadjistavropoulosTHerrKPrkachinKM, et al.Pain assessment in elderly adults with dementia. Lancet Neurol2014; 13: 1216–1227.
7.
ChowSChowRLamM, et al.Pain assessment tools for older adults with dementia in long-term care facilities: a systematic review. Neurodegener Dis Manag2016; 6: 525–538.
8.
PuLCoppietersMWSmalbruggeM, et al.Associations between facial expressions and observational pain in residents with dementia and chronic pain. J Adv Nurs2024; 80: 3846–3855.
9.
TsaiYIBrowneGInderKJ. Documented nursing practices of pain assessment and management when communicating about pain in dementia care. J Adv Nurs2022; 78: 3174–3186.
10.
ErsekMHerrKHilgemanMM, et al.Developing a pain intensity measure for persons with dementia: initial construction and testing. Pain Med2019; 20: 1078–1092.
11.
TappDChenacherSGerardNPA, et al.Observational pain assessment instruments for use with nonverbal patients at the end-of-life: a systematic review. J Palliat Care2019; 34: 255–266.
12.
SmithM. Pain assessment in nonverbal older adults with advanced dementia. Psychiatr Care2005; 41: 99–113.
13.
ChowSChowRLamM, et al.Pain assessment tools for older adults with dementia in long-term care facilities: a systematic review. Neurodegener Dis Manag2016; 6: 525–538.
14.
SmithTOHarveyK. Psychometric properties of pain measurements for people living with dementia: a COSMIN systematic review. Eur Geriatr Med2022; 13: 1029–1045.
15.
HadjistavropoulosTCraigKD. A theoretical framework for understanding self-report and observational measures of pain: a communications model. Behav Res Ther2002; 40: 551–570.
16.
LukasABarberJBJohnsonP, et al.Observer-rated pain assessment instruments improve both the detection of pain and the evaluation of pain intensity in people with dementia. Eur J Pain2013; 17: 1558–1568.
17.
McCahonSStrongJSharryR, et al.Self-report and pain behavior among patients with chronic pain. Clin J Pain2005; 21: 223–231.
18.
MartorellaGMiaoHWangD, et al.Feasibility, acceptability, and efficacy of home-based transcranial direct current stimulation on pain in older adults with Alzheimer's disease and related dementias: a randomized sham-controlled pilot clinical trial. J Clin Med2023; 12: 401.
19.
Pacheco-BarriosKCardenas-RojasAThibautA, et al.Methods and strategies of tDCS for the treatment of pain: current status and future directions. Expet Rev Med Dev2020; 17: 879–898.
20.
PeyronRLaurentBGarcía-LarreaL. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin2000; 30: 263–288.
21.
PengKYücelMAAastedCM, et al.Using prerecorded hemodynamic response functions in detecting prefrontal pain response: a functional near-infrared spectroscopy study. Neurophotonics2018; 5: 011018.
22.
LuoJZhuHQGouB, et al.Neuroimaging assessment of pain. Neurotherapeutics2022; 19: 1467–1488.
23.
DuboisJDuffyJGFieldRM, et al.A functional neuroimaging biomarker of mild cognitive impairment using TD-fNIRS. medRxiv2024.
24.
YennuATianFGatchelRJ, et al.Prefrontal hemodynamic mapping by functional near-infrared spectroscopy in response to thermal stimulations over three body sites. Neurophotonics2016; 3: 045008.
25.
HuYJiaYSunY, et al.Efficacy and safety of simultaneous rTMS-tDCS over bilateral angular gyrus on neuropsychiatric symptoms in patients with moderate Alzheimer's disease: a prospective, randomized, sham-controlled pilot study. Brain Stimul2022; 15: 1530–1537.
26.
ScholkmannFKleiserSMetzAJ, et al.A review on continuous wave functional near-infrared spectroscopy and imaging instrumentation and methodology. Neuroimage2014; 85 Pt 1(Pt 1): 6–27.
27.
HeroldFWiegelPScholkmannF, et al.Functional near-infrared spectroscopy in movement science: a systematic review on cortical activity in postural and walking tasks. Neurophotonics2017; 4: 041403.
28.
NiuHJLiXLChenY. Aberrant default mode network in amnestic mild cognitive impairment: a study combining fMRI and NIRS. Neurosci Lett2013; 533: 36–40.
29.
LiRNguyenTPotterT, et al.Dynamic cortical connectivity alterations associated with Alzheimer's disease: an EEG and fNIRS integration study. Neuroimage Clin2019; 21: 101622.
30.
BlumeFHudakJDreslerT, et al.NIRS-based neurofeedback training in a virtual reality classroom for children with attention-deficit/hyperactivity disorder: study protocol for a randomized controlled trial. Trials2017; 18: 41.
31.
Montero-HernandezSPolloniniLParkL, et al.Self-administered transcranial direct current stimulation treatment of knee osteoarthritis alters pain-related fNIRS connectivity networks. Neurophotonics2023; 10: 015011.
32.
CichanowiczCS. Comparative responsiveness of the numeric rating pain scale and the PEG scale among adult chronic pain patients in an ambulatory setting. The Catholic University of America, 2021.
33.
KatzMJWangCNesterCO, et al.T-MoCA: a valid phone screen for cognitive impairment in diverse community samples. Alzheimer's Dement2021; 13: e12144.
34.
FolsteinMFFolsteinSEMcHughPR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
35.
LefaucheurJPAntalAAyacheSS, et al.Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol2017; 128: 56–92.
36.
VergallitoAVaroliEPisoniA, et al.State-dependent effectiveness of cathodal transcranial direct current stimulation on cortical excitability. Neuroimage2023; 277: 120242.
37.
FolsteinMFFolsteinSEMcHughPR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
38.
LeeY-CLeeS-CChiuE-C. Practice effect and test-retest reliability of the Mini-Mental State Examination-2 in people with dementia. BMC Geriatr2022; 22: 67.
39.
TombaughTNMcIntyreNJ. The mini‐mental state examination: a comprehensive review. J Am Geriatr Soc1992; 40: 922–935.
40.
CiesielskaNSokołowskiRMazurE, et al.Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol2016; 50: 1039–1052.
41.
WongAXiongYYKwanPW, et al.The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord2009; 28: 81–87.
42.
MorrisJC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology1993; 43: 2412–2414.
43.
DworkinRHTurkDCMcDermottMP, et al.Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain2009; 146: 238–244.
44.
AlghadirAHAnwerSIqbalA, et al.Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res2018; 11: 851–856.
45.
HerrKAGarandL. Assessment and measurement of pain in older adults. Clin Geriatr Med2001; 17: 457–478.
HuseboBSStrandLIMoe-NilssenR, et al.Mobilization-Observation-Behavior-Intensity-Dementia Pain Scale (MOBID): development and validation of a nurse-administered pain assessment tool for use in dementia. J Pain Symptom Manag2007; 34: 67–80.
48.
AhnHZhongCMiaoH, et al.Efficacy of combining home-based transcranial direct current stimulation with mindfulness-based meditation for pain in older adults with knee osteoarthritis: a randomized controlled pilot study. J Clin Neurosci2019; 70: 140–145.
49.
TeresiJAYuXStewartAL, et al.Guidelines for designing and evaluating feasibility pilot studies. Med Care2022; 60: 95–103.
DelpyDTCopeMvan der ZeeP, et al.Estimation of optical pathlength through tissue from direct time of flight measurement. Phys Med Biol1988; 33: 1433–1442.
52.
HuppertTJDiamondSGFranceschiniMA, et al.HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain. Appl Opt2009; 48: D280–D298.
53.
YücelMAAastedCMPetkovMP, et al.Specificity of hemodynamic brain responses to painful stimuli: a functional near-infrared spectroscopy study. Sci Rep2015; 5: 9469.
54.
YennuATianFGatchelRJ, et al.Prefrontal hemodynamic mapping by functional near-infrared spectroscopy in response to thermal stimulations over three body sites. Neurophotonics2016; 3: 045008.
55.
Mac Giolla PhadraigCLawlerAMacHesneyG, et al.Are orofacial pain assessment tools for adults who cannot self‐report pain suitable for dental practice? A scoping review. Spec Care Dent2025; 45: e13089.
HuXSNascimentoTDDaSilvaAF. Shedding light on pain for the clinic: a comprehensive review of using functional near-infrared spectroscopy to monitor its process in the brain. Pain2021; 162: 2805–2820.
58.
Lopez-MartinezDPengKLeeA, et al.Pain detection with fNIRS-measured brain signals: a personalized machine learning approach using the wavelet transform and Bayesian hierarchical modeling with Dirichlet process priors. 2019 8th International Conference on Affective Computing and Intelligent Interaction Workshops and Demos (ACIIW). IEEE, 2019, pp. 304–309.
59.
HuffAJParkJMontero-HernandezS, et al.Functional near-infrared spectroscopy (fNIRS) detects brain changes for apathy and pain in patients with Alzheimer's disease and related dementias: an exploratory study. Neuroimage: Report2025; 5: 100266.
60.
YoonJAKongIJChoiI, et al.Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer's disease: an exploratory study. PLoS One2023; 18: e0285013.
61.
XieLLiuYGaoY, et al.Functional Near-Infrared Spectroscopy in neurodegenerative disease: a review. Front Neurosci2024; 18: 1469903.
62.
LiampasIDangaFKyriakoulopoulouP, et al.The contribution of functional near-infrared spectroscopy (fNIRS) to the study of neurodegenerative disorders: a narrative review. Diagnostics2024; 14: 663.
63.
CicalesePALiRAhmadiMB, et al.An EEG-fNIRS hybridization technique in the four-class classification of alzheimer's disease. J Neurosci Methods2020; 336: 108618.
64.
PerpetuiniDChiarelliAMFilippiniC, et al.Working memory decline in alzheimer's disease is detected by complexity analysis of multimodal EEG-fNIRS. Entropy2020; 22: 20201206.
65.
KarunakaranKDPengKGreenS, et al.Can pain under anesthesia be measured? Pain-related brain function using functional near-infrared spectroscopy during knee surgery. Neurophotonics2023; 10: 025014.
66.
DuJShiPFangF, et al.Cerebral cortical hemodynamic metrics to aid in assessing pain levels? a pilot study of functional near-infrared spectroscopy. Front Neurosci2023; 17: 1136820.
67.
YücelMALühmannAVScholkmannF, et al.Best practices for fNIRS publications. Neurophotonics2021; 8: 012101.
